Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Vor Biopharma Inc. VOR

Set alert

Price alert · VOR

All alert types
20.07 USD +0.82 +4.23%

As of Nov 3, 12:33 PM ET

Bid
20.06 × 1
Ask
20.11 × 1
18.93 Day range 20.63
6.50 52-week range 26.00
YTD
+53.40%
1 year
-10.46%
Open
19.45
Prev close
19.25
Mkt cap
1.23B
Vol
385.52K
Avg vol
946.76K
EPS
293.84
P/E
0.07
Div yield
0.00%
More statistics
Low
18.93
High
20.63
Forward P/E
-5.30
Beta
1.83
Short ratio
5.69
Inst. own
86.86%
Dividend
0.00
Ex-div date
Earnings
Mar 25, 2027
50-d avg
20.75
200-d avg
17.34
1y target
39.00

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 11, 2026Earnings: -1.16; estimate -0.69; surprise -68.12%
  • Aug 12, 2026Rating: Wedbush · Neutral → Neutral
  • Oct 21, 2026Rating: William Blair · — → Outperform
  • Oct 30, 2026Earnings: -1.45; estimate -1.07625; surprise -34.73%
Signals (12)
NameDateAgo
SMA: BearishOct 30, 20264 days ago
SMA: BullishOct 29, 20265 days ago
SMA: BullishOct 27, 20261 week ago
MACD: Buy SignalOct 9, 20263 weeks ago
SMA: BearishSep 23, 20261 month ago
SMA: BullishSep 21, 20261 month ago
SMA: BearishSep 18, 20261 month ago
SMA: BearishSep 10, 20261 month ago
MACD: Sell SignalSep 9, 20261 month ago
MACD: Buy SignalSep 8, 20261 month ago
MACD: Sell SignalAug 17, 20262 months ago
RSI: OverboughtAug 6, 20262 months ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 39.00 +94.4% upside
Target (low)
27.00
Target (mean)
39.00
Target (high)
50.00
Ratings (0m) 10 9 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy8
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 10
  • 1 month ago 9
  • 2 months ago 9

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

VOR analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.90-0.95 – -0.85307.53-100.3%00.0%2
Next quarter-0.9425-1.37 – -0.74-5.11+81.6%00.0%4
Current year-7.86-7.86 – -7.86-70.50+88.8%00.0%1
Next year-3.63-4.50 – -2.93-7.86+53.8%00.0%4

Upgrades and downgrades

The latest rating changes

VOR analyst upgrades and downgrades
DateFirmActionFromTo
Oct 21, 2026William BlairInitiated—Outperform
Aug 12, 2026WedbushMaintainedNeutralNeutral
May 18, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 14, 2026WedbushMaintainedNeutralNeutral
Apr 15, 2026HC Wainwright & Co.MaintainedBuyBuy
Mar 31, 2026WedbushMaintainedNeutralNeutral
Mar 30, 2026JefferiesInitiated—Buy
Mar 19, 2026Wells FargoInitiated—Overweight
Jan 9, 2026CitigroupInitiated—Buy
Dec 19, 2025JP MorganMaintainedOverweightOverweight
Dec 17, 2025TD CowenInitiated—Buy
Dec 9, 2025JP MorganInitiated—Overweight
Nov 14, 2025HC Wainwright & Co.MaintainedBuyBuy
Oct 29, 2025HC Wainwright & Co.MaintainedBuyBuy
Oct 15, 2025BairdUpgradeNeutralOutperform
Aug 14, 2025HC Wainwright & Co.ReiteratedBuyBuy
Jun 30, 2025HC Wainwright & Co.UpgradeNeutralBuy
Jun 27, 2025BairdMaintainedNeutralNeutral
Jun 26, 2025WedbushReiteratedNeutralNeutral
May 9, 2025JMP SecuritiesDowngradeMarket OutperformMarket Perform
May 9, 2025HC Wainwright & Co.DowngradeBuyNeutral
Mar 21, 2025OppenheimerReiteratedOutperformOutperform
Mar 21, 2025StifelMaintainedBuyBuy
Mar 21, 2025HC Wainwright & Co.MaintainedBuyBuy
Dec 10, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 10, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Nov 8, 2024BairdMaintainedOutperformOutperform
Nov 8, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 6, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Sep 6, 2024HC Wainwright & Co.ReiteratedBuyBuy